Adrenalectomy; Status

4

Review clinical trials related to Adrenalectomy; Status. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Tirzepatide Following Adrenalectomy in Mild Autonomous Cortisol Secretion

Mild Autonomous Cortisol Secretion (MACS) is a condition in which an adrenal gland produces excess cortisol and is associated with high blood pressure, diabetes, and weight gain. Surgical removal of the adrenal gland (adrenalectomy) is standard treatment, but some patients continue to have metabolic health problems after surgery. This randomized study will evaluate whether treatment with tirzepatide after adrenalectomy improves metabolic outcomes in patients with MACS compared with adrenalectomy alone.

Participants needed: 34
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Alaa SadaUpdated: Jul 1, 2026Locations: 1
Eligibility criteria

Adults aged 18 years and older [+4]

Bilateral adrenal lesions [+5]

Status: Recruiting

The Effect and Safety of Omitting Preoperative Alpha-adrenergic Blockade for Normotensive Pheochromocytoma

Pheochromocytoma and paraganglioma (PPGL) are rare neuroendocrine tumors originating from catecholamine producing chromaffin cells in the adrenal medulla and extra-adrenal paraganglia. The overall age-standardized incidence rate is 0.18 per 100,000 person-years in Korea. The definitive treatment of PPGL is surgical excision of tumor. However, surgery is associated with a high risk of perioperative hemodynamic instability (HI). To avoid perioperative HI in patients diagnosed with PPGL, preoperative management including routine use of alpha blockade and volume expansion has been advocated by several guidelines. While unstable hypertension and tachycardia should be controlled in patients with PPGL, there is controversial that all patients diagnosed with PPGL should undergo preoperative pharmacological treatment, especially alpha blockade. The most important risk of preoperative alpha blockade use is perioperative hypotension. A recent study reported that patients diagnosed with PPGL postoperatively may have no further higher risk of intraoperative hypertension than those diagnosed preoperatively despite insufficient preoperatively management of PPGL. Therefore, it is a very important to study the relationship between HI and preoperative alpha blockade in normotensive patients diagnosed with PPGL. The aim this study is to analyze the effect and safety of omitting preoperative alpha-adrenergic blockade for normotensive pheochromocytoma through a prospective randomized controlled trial. The patients is divided into two groups. The patients in control group take a phenoxybenzamine at least 2 to 5 weeks before surgery. The patients in case group do not take a phenoxybenzamine. Primary outcome is to evaluate the percentage of time during surgery with systolic blood pressure more than 160mmHg or average blood pressure less than 60mmHg. And secondary outcomes are to evaluate hemodynamic instability in preoperative ward and postoperative ward.

Participants needed: 24
Trial details
Phase: Phase 4Age: 19-70Biological sex: AllType: InterventionalSponsor: Seoul National University HospitalUpdated: Jun 12, 2025Locations: 1
Eligibility criteria

Patients aged 19 to 70 years old [+2]

Patients under 18 or over 70 years old [+9]

Status: Recruiting

3D Laparoscopic Adrenalectomies for Adrenal Tumors

The main drawbacks of conventional 2D laparoscopy are limited depth perception and loss of spatial orientation. High-quality 3D laparoscopy systems might improve surgical outcomes for adrenalectomy.

Participants needed: 300
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Institut d'Investigació Biomèdica de Girona Dr. Josep TruetaUpdated: May 9, 2025Locations: 1
Eligibility criteria

All adult patients (age ≥ 18 years) [+2]

Emergency surgery. [+4]

Status: Recruiting

Surgical Treatment of Adrenal Diseases- Laparoscopic vs. Robotic-assisted Adrenalectomy

The goal of this multicenter, observational, analytic, randomized clinical trial is to analyze the laparoscopic and robot-assisted method in the surgical treatment of patients with adrenal diseases. The main question it aims to answer are: 1. to find the superiority of one the the surgical method mentioned above 2. to compare the quality of life in patients with adrenal mass before surgery and after laparoscopic or robotic-assisted adrenalectomy.

Participants needed: 100
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: University Hospital OlomoucUpdated: Sep 22, 2023Locations: 1
Eligibility criteria

Indicated adrenalectomy based on endocrinological and imaging examination. [+1]

Simultaneous bilateral adrenalectomy. [+2]